Alan Mateo - Veeva Systems Executive Vice President of Global Sales
VEEV Stock | USD 235.21 1.96 0.83% |
President
Mr. Alan V. Mateo is Executive Vice President of Global Sales of the company since April 2015. He has served as our Executive Vice President, Global Sales since April 2015. Prior to joining Veeva, Mr. Mateo served in various executive roles at Medidata Solutions, Inc., a provider of a platform of cloudbased solutions for life sciences, from March 2005 to February 2015, including as Executive Vice President of Field Operations from January 2014 to February 2015. Before Medidata, Mr. Mateo spent 11 years at PeopleSoft, where his responsibilities included product lines sales, sales operations and the integration of JD Edwards into PeopleSofts global sales organization. Prior to PeopleSoft, Mr. Mateo was northeast sales director for Red Pepper Software Co., a provider of supply chain management planning application software, and a major account executive at JD Edwards since 2015.
Age | 62 |
Tenure | 10 years |
Address | 4280 Hacienda Drive, Pleasanton, CA, United States, 94588 |
Phone | 925 452 6500 |
Web | https://www.veeva.com |
Latest Insider Transactions
Mateo earned a BS in both Computer Science and Marketing from Juniata College.Veeva Systems Management Efficiency
The company has return on total asset (ROA) of 0.0657 % which means that it generated a profit of $0.0657 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1363 %, meaning that it created $0.1363 on every $100 dollars invested by stockholders. Veeva Systems' management efficiency ratios could be used to measure how well Veeva Systems manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Veeva Systems' Return On Tangible Assets are fairly stable compared to the past year. Return On Assets is likely to climb to 0.12 in 2025, whereas Return On Capital Employed is likely to drop 0.1 in 2025. At this time, Veeva Systems' Fixed Asset Turnover is fairly stable compared to the past year. Return On Assets is likely to climb to 0.12 in 2025, whereas Intangible Assets are likely to drop slightly above 55.5 M in 2025.Similar Executives
Showing other executives | PRESIDENT Age | ||
Patrick PharmD | Certara | 54 | |
Gabriel Cappucci | Teladoc | 56 | |
Karen Akinsanya | Schrodinger | 57 | |
Elie Chaillot | GE HealthCare Technologies | N/A | |
Mike Walsh | Goodrx Holdings | N/A | |
Robert Aspbury | Certara | 53 | |
Kelsi Harris | Accolade | N/A | |
Carlos Nueno | Teladoc | N/A | |
Thomas Westrick | GE HealthCare Technologies | 56 | |
Laizer Kornwasser | Teladoc | 53 | |
Bansi Nagji | Goodrx Holdings | 60 | |
Andrew Turitz | Teladoc | 51 | |
Catherine Estrampes | GE HealthCare Technologies | N/A | |
Leif Pedersen | Certara | 60 | |
Jan Makela | GE HealthCare Technologies | 55 | |
Andy Puterbaugh | Teladoc | N/A | |
Alon Matas | Teladoc | N/A | |
Kevin ONeill | GE HealthCare Technologies | 55 | |
Delano Ladd | HealthEquity | 43 | |
Larry Trittschuh | HealthEquity | 52 | |
Roland Rott | GE HealthCare Technologies | 52 |
Management Performance
Return On Equity | 0.14 | ||||
Return On Asset | 0.0657 |
Veeva Systems Class Leadership Team
Elected by the shareholders, the Veeva Systems' board of directors comprises two types of representatives: Veeva Systems inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Veeva. The board's role is to monitor Veeva Systems' management team and ensure that shareholders' interests are well served. Veeva Systems' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Veeva Systems' outside directors are responsible for providing unbiased perspectives on the board's policies.
Jonathan JD, General VP | ||
Ato Garrett, Director Relations | ||
Paul Sekhri, Independent Director | ||
Matthew Wallach, Co-Founder and Pres | ||
Timothy Barabe, Independent Director | ||
Alan Mateo, Executive Vice President of Global Sales | ||
Pinal Patel, Chief Officer | ||
Eleni Zuppas, President Staff | ||
Kristine Diamond, Principal Officer | ||
Jonathan Faddis, Senior Vice President, General Counsel, Corporate Secretary | ||
Jacques Mourrain, Regulatory Quality | ||
Vivian Welsh, Chief Officer | ||
Timothy Cabral, Interim Director | ||
Ronald Codd, Independent Director | ||
Matthew Robinson, Chief Officer | ||
Peter Gassner, Chief Executive Officer, Director | ||
Michele OConnor, Principal Accounting Officer | ||
Frederic Lequient, Senior Vice President - Global Customer Services | ||
Tina Hunt, Director | ||
Paul Chamberlain, Independent Director | ||
Brian Wagener, Chief Officer | ||
Mark Carges, Independent Director | ||
Gordon Ritter, Independent Chairman of the Board | ||
Priscilla Hung, Director | ||
Gunnar Hansen, Director Relations | ||
Mary Hedley, Independent Director | ||
E Zuppas, Chief Marketing Officer | ||
Brent Bowman, Chief Financial Officer | ||
Thomas Schwenger, President, Chief Operating Officer | ||
Marshall Mohr, Director |
Veeva Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Veeva Systems a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.14 | ||||
Return On Asset | 0.0657 | ||||
Profit Margin | 0.26 % | ||||
Operating Margin | 0.26 % | ||||
Current Valuation | 33.43 B | ||||
Shares Outstanding | 162.35 M | ||||
Shares Owned By Insiders | 8.91 % | ||||
Shares Owned By Institutions | 84.90 % | ||||
Number Of Shares Shorted | 4 M | ||||
Price To Earning | 78.67 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Veeva Stock Analysis
When running Veeva Systems' price analysis, check to measure Veeva Systems' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veeva Systems is operating at the current time. Most of Veeva Systems' value examination focuses on studying past and present price action to predict the probability of Veeva Systems' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veeva Systems' price. Additionally, you may evaluate how the addition of Veeva Systems to your portfolios can decrease your overall portfolio volatility.